348 related articles for article (PubMed ID: 21981787)
1. The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases.
Sebastiani G; Castera L; Halfon P; Pol S; Mangia A; Di Marco V; Pirisi M; Voiculescu M; Bourliere M; Alberti A
Aliment Pharmacol Ther; 2011 Nov; 34(10):1202-16. PubMed ID: 21981787
[TBL] [Abstract][Full Text] [Related]
2. Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02.
Cacoub P; Carrat F; Bédossa P; Lambert J; Pénaranda G; Perronne C; Pol S; Halfon P
J Hepatol; 2008 May; 48(5):765-73. PubMed ID: 18314219
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?
Maor Y; Bashari D; Kenet G; Lubetsky A; Luboshitz J; Schapiro JM; Pénaranda G; Bar-Meir S; Martinowitz U; Halfon P
Haemophilia; 2006 Jul; 12(4):372-9. PubMed ID: 16834736
[TBL] [Abstract][Full Text] [Related]
4. Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C.
Sebastiani G; Halfon P; Castera L; Mangia A; Di Marco V; Pirisi M; Voiculescu M; Bourliere M; Alberti A
Aliment Pharmacol Ther; 2012 Jan; 35(1):92-104. PubMed ID: 22035045
[TBL] [Abstract][Full Text] [Related]
5. Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients.
Stibbe KJ; Verveer C; Francke J; Hansen BE; Zondervan PE; Kuipers EJ; de Knegt RJ; van Vuuren AJ
Scand J Gastroenterol; 2011 Jul; 46(7-8):962-72. PubMed ID: 21623677
[TBL] [Abstract][Full Text] [Related]
6. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
McPherson S; Stewart SF; Henderson E; Burt AD; Day CP
Gut; 2010 Sep; 59(9):1265-9. PubMed ID: 20801772
[TBL] [Abstract][Full Text] [Related]
7. Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration.
Castera L; Winnock M; Pambrun E; Paradis V; Perez P; Loko MA; Asselineau J; Dabis F; Degos F; Salmon D
HIV Med; 2014 Jan; 15(1):30-9. PubMed ID: 24007567
[TBL] [Abstract][Full Text] [Related]
8. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
[TBL] [Abstract][Full Text] [Related]
9. Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients.
Bottero J; Lacombe K; Guéchot J; Serfaty L; Miailhes P; Bonnard P; Wendum D; Molina JM; Lascoux-Combe C; Girard PM
J Hepatol; 2009 Jun; 50(6):1074-83. PubMed ID: 19398234
[TBL] [Abstract][Full Text] [Related]
10. Validation of three non-invasive markers in assessing the severity of liver fibrosis in chronic hepatitis C.
Shaikh S; Memon MS; Ghani H; Baloch GH; Jaffery M; Shaikh K
J Coll Physicians Surg Pak; 2009 Aug; 19(8):478-82. PubMed ID: 19651008
[TBL] [Abstract][Full Text] [Related]
11. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.
Sebastiani G; Vario A; Guido M; Alberti A
J Viral Hepat; 2008 Mar; 15(3):212-8. PubMed ID: 18179453
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive markers of hepatic fibrosis in patients co-infected with HCV and HIV: comparison of the APRI and FIB-4 index.
Trang T; Petersen JR; Snyder N
Clin Chim Acta; 2008 Nov; 397(1-2):51-4. PubMed ID: 18692034
[TBL] [Abstract][Full Text] [Related]
13. Correlation of transient elastography with APRI and FIB-4 in a cohort of patients with congenital bleeding disorders and HCV or HIV/HCV coinfection.
Vidovic N; Lochowsky RS; Goldmann G; Rockstroh J; Wasmuth JC; Spengler U; Sauerbruch T; Lammert F; Oldenburg J; Grünhage F
Haemophilia; 2010 Sep; 16(5):778-85. PubMed ID: 20331759
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of diagnostic accuracy of APRI for prediction of fibrosis in hepatitis C patients.
Khan DA; Fatima-Tuz-Zuhra ; Khan FA; Mubarak A
J Ayub Med Coll Abbottabad; 2008; 20(4):122-6. PubMed ID: 19999223
[TBL] [Abstract][Full Text] [Related]
15. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.
Carvalho-Filho RJ; Schiavon LL; Narciso-Schiavon JL; Sampaio JP; Lanzoni VP; Ferraz ML; Silva AE
Liver Int; 2008 Apr; 28(4):486-93. PubMed ID: 18339075
[TBL] [Abstract][Full Text] [Related]
16. Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease.
Adams LA; George J; Bugianesi E; Rossi E; De Boer WB; van der Poorten D; Ching HL; Bulsara M; Jeffrey GP
J Gastroenterol Hepatol; 2011 Oct; 26(10):1536-43. PubMed ID: 21950746
[TBL] [Abstract][Full Text] [Related]
17. Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort.
Loko MA; Castera L; Dabis F; Le Bail B; Winnock M; Coureau G; Bioulac-Sage P; de Ledinghen V; Neau D;
Am J Gastroenterol; 2008 Aug; 103(8):1973-80. PubMed ID: 18796094
[TBL] [Abstract][Full Text] [Related]
18. Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection.
Calès P; Halfon P; Batisse D; Carrat F; Perré P; Penaranda G; Guyader D; d'Alteroche L; Fouchard-Hubert I; Michelet C; Veillon P; Lambert J; Weiss L; Salmon D; Cacoub P
J Hepatol; 2010 Aug; 53(2):238-44. PubMed ID: 20493576
[TBL] [Abstract][Full Text] [Related]
19. Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy.
Schmid P; Bregenzer A; Huber M; Rauch A; Jochum W; Müllhaupt B; Vernazza P; Opravil M; Weber R;
PLoS One; 2015; 10(9):e0138838. PubMed ID: 26418061
[TBL] [Abstract][Full Text] [Related]
20. The Diagnostic Accuracy and Clinical Utility of Three Noninvasive Models for Predicting Liver Fibrosis in Patients with HBV Infection.
Zhang Z; Wang G; Kang K; Wu G; Wang P
PLoS One; 2016; 11(4):e0152757. PubMed ID: 27050531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]